Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
16
XRAY Quote, Financials, Valuation and Earnings
Last price:
$15.74
Seasonality move
:
2.26%
Day range:
$15.39 - $15.89
52-week range:
$14.78 - $33.72
Dividend yield:
4.11%
P/E ratio:
--
P/S ratio:
0.83x
P/B ratio:
1.59x
Volume:
4.5M
Avg. volume:
2.8M
1-year change:
-52.53%
Market cap:
$3.1B
Revenue:
$3.8B
EPS (TTM):
-$4.55
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Revenue Growth (YoY) | -16.98% | 26.72% | -7.3% | 1.1% | -4.34% | |
| Cost of Revenues | $1.7B | $1.9B | $1.8B | $1.9B | $1.8B | |
| Gross Profit | $1.7B | $2.3B | $2.1B | $2.1B | $2B | |
| Gross Profit Margin | 49.6% | 55.47% | 54.23% | 52.61% | 51.62% | |
| R&D Expenses | $123M | $171M | $174M | $184M | $165M | |
| Selling, General & Admin | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$235M | -$19M | -$1.4B | -$383M | -$1.1B | |
| Operating Expenses | $1.4B | $1.7B | $1.8B | $1.8B | $1.8B | |
| Operating Income | $231M | $625M | $364M | $289M | $188M | |
| Net Interest Expenses | $46M | $61M | $65M | $81M | $69M | |
| EBT. Incl. Unusual Items | -$50M | $545M | -$1.1B | -$175M | -$936M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $23M | $134M | -$105M | -$43M | -$26M | |
| Net Income to Company | -$73M | $411M | -$950M | -$132M | -$910M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$73M | $411M | -$950M | -$132M | -$910M | |
| Basic EPS (Cont. Ops) | -$0.33 | $1.88 | -$4.41 | -$0.62 | -$4.48 | |
| Diluted EPS (Cont. Ops) | -$0.33 | $1.87 | -$4.41 | -$0.62 | -$4.48 | |
| Weighted Average Basic Share | $219.2M | $218.4M | $215.5M | $212M | $203.2M | |
| Weighted Average Diluted Share | $219.2M | $220.2M | $215.5M | $212M | $203.2M | |
| EBITDA | $330M | $952M | -$662M | $249M | -$518M | |
| EBIT | -$4M | $606M | -$990M | -$94M | -$867M | |
| Revenue (Reported) | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Operating Income (Reported) | $231M | $625M | $364M | $289M | $188M | |
| Operating Income (Adjusted) | -$4M | $606M | -$990M | -$94M | -$867M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $983M | $1B | $905M | |
| Revenue Growth (YoY) | -2.56% | 2.51% | -10.88% | 2.95% | -10.57% | |
| Cost of Revenues | $509M | $499M | $466M | $490M | $459M | |
| Gross Profit | $567M | $604M | $517M | $522M | $446M | |
| Gross Profit Margin | 52.7% | 54.76% | 52.59% | 51.58% | 49.28% | |
| R&D Expenses | $38M | $49M | $43M | $43M | $42M | |
| Selling, General & Admin | $373M | $377M | $402M | $404M | $395M | |
| Other Inc / (Exp) | -$12M | -$4M | -$40M | $2M | -$516M | |
| Operating Expenses | $411M | $426M | $445M | $447M | $437M | |
| Operating Income | $156M | $178M | $72M | $75M | $9M | |
| Net Interest Expenses | $15M | $18M | $24M | $20M | $16M | |
| EBT. Incl. Unusual Items | $129M | $156M | $8M | $57M | -$523M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $24M | $37M | $23M | -$15M | -$95M | |
| Net Income to Company | $105M | $119M | -$15M | $72M | -$428M | |
| Minority Interest in Earnings | -- | -- | -- | -$5M | -$2M | |
| Net Income to Common Excl Extra Items | $105M | $119M | -$15M | $67M | -$430M | |
| Basic EPS (Cont. Ops) | $0.45 | $0.47 | -$0.07 | $0.32 | -$2.16 | |
| Diluted EPS (Cont. Ops) | $0.45 | $0.47 | -$0.07 | $0.32 | -$2.16 | |
| Weighted Average Basic Share | $218.6M | $217.8M | $215.2M | $209.9M | $198.7M | |
| Weighted Average Diluted Share | $218.6M | $218.7M | $215.2M | $209.9M | $198.7M | |
| EBITDA | $231M | $259M | $111M | $162M | -$419M | |
| EBIT | $144M | $174M | $32M | $77M | -$507M | |
| Revenue (Reported) | $1.1B | $1.1B | $983M | $1B | $905M | |
| Operating Income (Reported) | $156M | $178M | $72M | $75M | $9M | |
| Operating Income (Adjusted) | $144M | $174M | $32M | $77M | -$507M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.7B | $1.9B | $1.8B | $1.9B | $1.8B | |
| Gross Profit | $1.6B | $2.3B | $2.1B | $2.1B | $2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $119M | $171M | $174M | $184M | $165M | |
| Selling, General & Admin | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$235M | -$19M | -$1.4B | -$383M | -$1.1B | |
| Operating Expenses | $1.4B | $1.7B | $1.8B | $1.8B | $1.8B | |
| Operating Income | $218M | $625M | $364M | $289M | $189M | |
| Net Interest Expenses | $47M | $61M | $65M | $81M | $69M | |
| EBT. Incl. Unusual Items | -$64M | $545M | -$1.1B | -$175M | -$936M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19M | $134M | -$105M | -$43M | -$26M | |
| Net Income to Company | -$73M | $411M | -$950M | -$132M | -$910M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$83M | $411M | -$950M | -$132M | -$910M | |
| Basic EPS (Cont. Ops) | -$0.40 | $1.81 | -$4.42 | -$0.61 | -$4.55 | |
| Diluted EPS (Cont. Ops) | -$0.40 | $1.79 | -$4.42 | -$0.62 | -$4.55 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $317M | $952M | -$662M | $249M | -$518M | |
| EBIT | -$17M | $606M | -$990M | -$94M | -$867M | |
| Revenue (Reported) | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Operating Income (Reported) | $218M | $625M | $364M | $289M | $189M | |
| Operating Income (Adjusted) | -$17M | $606M | -$990M | -$94M | -$867M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $3.9B | $4B | $3.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.9B | $1.8B | $1.9B | $1.8B | -- | |
| Gross Profit | $2.3B | $2.1B | $2.1B | $2B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $171M | $174M | $184M | $165M | -- | |
| Selling, General & Admin | $1.6B | $1.6B | $1.6B | $1.6B | -- | |
| Other Inc / (Exp) | -$19M | -$1.4B | -$383M | -$1.1B | -- | |
| Operating Expenses | $1.7B | $1.8B | $1.8B | $1.8B | -- | |
| Operating Income | $625M | $364M | $289M | $189M | -- | |
| Net Interest Expenses | $61M | $65M | $81M | $69M | -- | |
| EBT. Incl. Unusual Items | $545M | -$1.1B | -$175M | -$936M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $134M | -$105M | -$43M | -$26M | -- | |
| Net Income to Company | $411M | -$950M | -$132M | -$910M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $411M | -$950M | -$132M | -$910M | -- | |
| Basic EPS (Cont. Ops) | $1.81 | -$4.42 | -$0.61 | -$4.55 | -- | |
| Diluted EPS (Cont. Ops) | $1.79 | -$4.42 | -$0.62 | -$4.55 | -- | |
| Weighted Average Basic Share | $873.6M | $862M | $848.1M | $812.7M | -- | |
| Weighted Average Diluted Share | $879.8M | $863.2M | $849.3M | $813.8M | -- | |
| EBITDA | $952M | -$662M | $249M | -$518M | -- | |
| EBIT | $606M | -$990M | -$94M | -$867M | -- | |
| Revenue (Reported) | $4.2B | $3.9B | $4B | $3.8B | -- | |
| Operating Income (Reported) | $625M | $364M | $289M | $189M | -- | |
| Operating Income (Adjusted) | $606M | -$990M | -$94M | -$867M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $438M | $339M | $365M | $334M | $272M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $667M | $750M | $632M | $695M | $556M | |
| Inventory | $476M | $515M | $627M | $624M | $564M | |
| Prepaid Expenses | $111M | $111M | $128M | $146M | $151M | |
| Other Current Assets | $67M | $84M | $88M | $113M | $153M | |
| Total Current Assets | $1.8B | $1.9B | $1.9B | $2B | $1.7B | |
| Property Plant And Equipment | $967M | $971M | $961M | $978M | $902M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4B | $4B | $2.7B | $2.4B | $1.6B | |
| Other Intangibles | $2.5B | $2.3B | $1.9B | $1.7B | $1.2B | |
| Other Long-Term Assets | $95M | $121M | $198M | $276M | $301M | |
| Total Assets | $9.4B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Accounts Payable | $302M | $262M | $279M | $305M | $241M | |
| Accrued Expenses | $432M | $424M | $401M | $427M | $480M | |
| Current Portion Of Long-Term Debt | $299M | $12M | $23M | $97M | $139M | |
| Current Portion Of Capital Lease Obligations | $48M | $50M | $54M | $56M | $46M | |
| Other Current Liabilities | $32M | $3M | $19M | $18M | $12M | |
| Total Current Liabilities | $1.4B | $1.3B | $1.2B | $1.4B | $1.6B | |
| Long-Term Debt | $2B | $1.9B | $1.8B | $1.8B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.4B | $4.2B | $3.8B | $4.1B | $3.8B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$464M | -$592M | -$628M | -$636M | -$730M | |
| Common Equity | $4.9B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3M | $1M | $1M | $1M | $1M | |
| Total Equity | $4.9B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Liabilities and Equity | $9.4B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Cash and Short Terms | $438M | $339M | $365M | $334M | $272M | |
| Total Debt | $2.3B | $2.1B | $1.9B | $2.1B | $2.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $438M | $339M | $365M | $334M | $272M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $667M | $750M | $632M | $695M | $556M | |
| Inventory | $476M | $515M | $627M | $624M | $564M | |
| Prepaid Expenses | $111M | $111M | $128M | $146M | $151M | |
| Other Current Assets | $67M | $84M | $88M | $113M | $153M | |
| Total Current Assets | $1.8B | $1.9B | $1.9B | $2B | $1.7B | |
| Property Plant And Equipment | $967M | $971M | $961M | $978M | $902M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $4B | $4B | $2.7B | $2.4B | $1.6B | |
| Other Intangibles | $2.5B | $2.3B | $1.9B | $1.7B | $1.2B | |
| Other Long-Term Assets | $95M | $121M | $198M | $276M | $301M | |
| Total Assets | $9.4B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Accounts Payable | $302M | $262M | $279M | $305M | $241M | |
| Accrued Expenses | $432M | $424M | $401M | $427M | $480M | |
| Current Portion Of Long-Term Debt | $299M | $12M | $23M | $97M | $139M | |
| Current Portion Of Capital Lease Obligations | $48M | $50M | $54M | $56M | $46M | |
| Other Current Liabilities | $32M | $3M | $19M | $18M | $12M | |
| Total Current Liabilities | $1.4B | $1.3B | $1.2B | $1.4B | $1.6B | |
| Long-Term Debt | $2B | $1.9B | $1.8B | $1.8B | $1.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.4B | $4.2B | $3.8B | $4.1B | $3.8B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$464M | -$592M | -$628M | -$636M | -$730M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3M | $1M | $1M | $1M | $1M | |
| Total Equity | $4.9B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Liabilities and Equity | $9.4B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Cash and Short Terms | $438M | $339M | $365M | $334M | $272M | |
| Total Debt | $2.3B | $2.1B | $1.9B | $2.1B | $2.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$73M | $411M | -$950M | -$132M | -$910M | |
| Depreciation & Amoritzation | $334M | $346M | $328M | $343M | $349M | |
| Stock-Based Compensation | $47M | $48M | $59M | $46M | $39M | |
| Change in Accounts Receivable | $131M | -$117M | $85M | -$58M | $104M | |
| Change in Inventories | $123M | -$64M | -$141M | $6M | $17M | |
| Cash From Operations | $649M | $657M | $517M | $377M | $461M | |
| Capital Expenditures | $87M | $142M | $149M | $149M | $180M | |
| Cash Acquisitions | -$1.1B | -$220M | -- | $13M | -- | |
| Cash From Investing | -$1.1B | -$358M | -$138M | -$89M | -$197M | |
| Dividends Paid (Ex Special Dividend) | -- | -$92M | -$104M | -$116M | -$126M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $16M | $6M | -- | $1M | |
| Long-Term Debt Repaid | -$701M | -$297M | -$2M | -$7M | -$88M | |
| Repurchase of Common Stock | -$228M | -$200M | -$150M | -$300M | -$250M | |
| Other Financing Activities | -$56M | -$36M | -$15M | -$10M | -$16M | |
| Cash From Financing | $476M | -$379M | -$329M | -$307M | -$302M | |
| Beginning Cash (CF) | $405M | $438M | $339M | $365M | $334M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19M | -$80M | $50M | -$19M | -$38M | |
| Ending Cash (CF) | $438M | $339M | $365M | $334M | $272M | |
| Levered Free Cash Flow | $562M | $515M | $368M | $228M | $281M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $105M | $119M | -$15M | $72M | -$428M | |
| Depreciation & Amoritzation | $87M | $85M | $79M | $85M | $88M | |
| Stock-Based Compensation | $11M | -$6M | $12M | $13M | $4M | |
| Change in Accounts Receivable | -$19M | -$28M | $42M | -$27M | $85M | |
| Change in Inventories | $50M | $24M | -$1M | $51M | $15M | |
| Cash From Operations | $264M | $222M | $142M | $160M | $87M | |
| Capital Expenditures | $27M | $41M | $32M | $40M | $51M | |
| Cash Acquisitions | -$1.1B | $1M | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$39M | -$29M | -$20M | -$57M | |
| Dividends Paid (Ex Special Dividend) | $66M | -$24M | -$26M | -$30M | -$31M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1M | -$146M | -$65M | -$70M | -$98M | |
| Long-Term Debt Repaid | -- | -- | -- | -$1M | -$80M | |
| Repurchase of Common Stock | -$88M | -$110M | -- | -$150M | -- | |
| Other Financing Activities | -- | -$25M | -- | -$3M | -$6M | |
| Cash From Financing | -$15M | -$122M | -$161M | -$128M | -$38M | |
| Beginning Cash (CF) | $1.3B | $281M | $418M | $309M | $296M | |
| Foreign Exchange Rate Adjustment | $18M | -$3M | -$5M | $13M | -$16M | |
| Additions / Reductions | -$852M | $61M | -$48M | $12M | -$8M | |
| Ending Cash (CF) | $438M | $339M | $365M | $334M | $272M | |
| Levered Free Cash Flow | $237M | $181M | $110M | $120M | $36M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$73M | $411M | -$950M | -$132M | -$910M | |
| Depreciation & Amoritzation | $334M | $346M | $328M | $343M | $349M | |
| Stock-Based Compensation | $47M | $48M | $59M | $46M | $39M | |
| Change in Accounts Receivable | $131M | -$117M | $85M | -$58M | $104M | |
| Change in Inventories | $123M | -$64M | -$141M | $6M | $17M | |
| Cash From Operations | $649M | $657M | $517M | $377M | $461M | |
| Capital Expenditures | $87M | $142M | $149M | $149M | $180M | |
| Cash Acquisitions | -$1.1B | -$220M | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$358M | -$138M | -$89M | -$197M | |
| Dividends Paid (Ex Special Dividend) | -- | -$92M | -$104M | -$116M | -$126M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $16M | $6M | -- | $1M | |
| Long-Term Debt Repaid | -$701M | -$297M | -$2M | -$7M | -$88M | |
| Repurchase of Common Stock | -$228M | -$200M | -$150M | -$300M | -$250M | |
| Other Financing Activities | -$56M | -$36M | -$15M | -$10M | -$16M | |
| Cash From Financing | $476M | -$379M | -$329M | -$307M | -$302M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19M | -$80M | $50M | -$19M | -$38M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $562M | $515M | $368M | $228M | $281M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $411M | -$950M | -$132M | -$910M | -- | |
| Depreciation & Amoritzation | $346M | $328M | $343M | $349M | -- | |
| Stock-Based Compensation | $48M | $59M | $46M | $39M | -- | |
| Change in Accounts Receivable | -$117M | $85M | -$58M | $104M | -- | |
| Change in Inventories | -$64M | -$141M | $6M | $17M | -- | |
| Cash From Operations | $657M | $517M | $377M | $461M | -- | |
| Capital Expenditures | $142M | $149M | $149M | $180M | -- | |
| Cash Acquisitions | -$220M | -- | -- | -- | -- | |
| Cash From Investing | -$358M | -$138M | -$89M | -$197M | -- | |
| Dividends Paid (Ex Special Dividend) | -$92M | -$104M | -$116M | -$126M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $16M | $6M | -- | $1M | -- | |
| Long-Term Debt Repaid | -$297M | -$2M | -$7M | -$88M | -- | |
| Repurchase of Common Stock | -$200M | -$150M | -$300M | -$250M | -- | |
| Other Financing Activities | -$36M | -$15M | -$10M | -$16M | -- | |
| Cash From Financing | -$379M | -$329M | -$307M | -$302M | -- | |
| Beginning Cash (CF) | $1.4B | $1.5B | $1.3B | $1.2B | -- | |
| Foreign Exchange Rate Adjustment | -$19M | -$24M | -$12M | -$24M | -- | |
| Additions / Reductions | -$80M | $50M | -$19M | -$38M | -- | |
| Ending Cash (CF) | $1.3B | $1.5B | $1.3B | $1.1B | -- | |
| Levered Free Cash Flow | $515M | $368M | $228M | $281M | -- | |
Get XRAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XRAY
Sector
P/E ratio
--
24.13x
PEG ratio
-0.01x
0.00x
P/B ratio
1.59x
1.69x
Price / LTM sales
0.83x
1.71x
Growth Metrics
XRAY
Sector
Revenue growth
-10.57%
6.54%
Earnings growth
--
6.3%
Revenue (5-year growth)
-1.17%
9.13%
Earnings forecast
$0.43
-$0.20
Profitability
XRAY
Sector
Profitability FY 2024
$2B
$57.1M
Return on invested capital
-18.42%
-14.96%
Return on assets
-13.47%
-12.4%
Return on equity
-32.39%
-17.27%
Earnings Date
Last Earnings Date
Feb
27
Next Earnings Date
May
2
Estimated Next Earnings Date
May
29
Balance Sheet
XRAY
Sector
Total cash
$272M
$44.5M
Short term investments
--
$39.2M
Total assets
$5.8B
$126.6M
Long term debt
$2.1B
$9.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
